| All patients (n = 90) | Smear method (n = 52) | LBC (n = 38) | P value |
---|---|---|---|---|
Age (IQR), years | 70 (65–74) | 69 (64–73) | 72 (67–76) | 0.084 |
Sex (male/female) | 59/31 | 37/15 | 22/16 | 0.191 |
Location of main lesion (Ph/Pbt) | 50/40 | 30/22 | 20/18 | 0.633 |
Type of IPMN, n (%) | 0.075 | |||
  BD | 33 (37) | 21 (40) | 12 (32) |  |
  Mixed | 43 (48) | 20 (38) | 23 (61) |  |
  MD | 14 (16) | 11 (21) | 3 (8) |  |
Pathological diagnosis, n (%) | 0.626 | |||
  L-IGD | 47 (52) | 24 (46) | 23 (61) |  |
  HGD | 15 (17) | 10 (19) | 5 (13) |  |
  IC | 28 (31) | 18 (35) | 10 (26) |  |
Diameter of dilated branch duct (IQR), mm | 27.0 (17.0–40.3) | 30.0 (11.0–42.5) | 26.0 (19.8–36.8) | 0.990 |
 ≥ 30 mm, n (%) | 41 (46) | 27 (52) | 14 (37) | 0.156 |
Diameter of MPD (IQR), mm | 6.0 (4.0–10.0) | 6.0 (4.1–10.0) | 6.4 (4.0–10.0) | 0.928 |
 5–9 mm, n (%) | 35 (39) | 20 (38) | 15 (39) | 0.923 |
 ≥ 10 mm, n (%) | 23 (26) | 14 (27) | 9 (24) | 0.728 |
Patients with MN, n (%) | 67 (74) | 39 (75) | 28 (74) | 0.888 |
 Height of MN (IQR), mm | 7.0 (4.0–15.0) | 7.0 (4.0–13.0) | 9.5 (4.0–17.5) | 0.366 |
 Enhancing MN ≥ 5 mm, n (%) | 31 (46) | 15 (38) | 16 (57) | 0.130 |
SPACE, n (%) | 12 (13) | 1 (2) | 11 (29) | < .001 |